Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
Clinical trial NCT00172055 · COMPLETED
Trial details
- NCT number
- NCT00172055
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2009-07-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.